{
  "pmid": "41357738",
  "title": "Clinical and Economic Burden of COPD in Patients on Inhaled Triple Therapy in Germany - A Retrospective Claims Data Analysis.",
  "abstract": "This study describes the pharmacological treatment as well as the clinical and economic burden of disease in chronic obstructive pulmonary disease (COPD) patients initiating triple therapy (TT) defined as a combination of a long-acting muscarinic antagonist (LAMA), a long-acting beta2-agonist (LABA) and an inhaled corticosteroid (ICS) in Germany.",
  "authors": [
    "Anna Carina Meyer",
    "Denis Azabdaftari",
    "Inka Albrecht",
    "Marie Schild",
    "Nils Kossack"
  ],
  "journal": "International journal of chronic obstructive pulmonary disease",
  "year": "",
  "keywords": [
    "costs",
    "exacerbation",
    "healthcare resource utilization",
    "roflumilast",
    "treatment"
  ],
  "source": "pubmed",
  "collected_at": "2026-01-07T20:03:01.099274"
}